52314 Federal Register / Vol. 82, No. 217 / Monday, November 13, 2017 / Notices 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2017–24495 Filed 11–9–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act 

(FACA), notice is hereby given that a 

meeting is scheduled for the Advisory 

Commission on Childhood Vaccines 

(ACCV). This meeting will be open to 

the public. Information about the ACCV 

and the agenda for this meeting can be 

obtained by accessing the following 

Web site: http://www.hrsa.gov/ 

advisorycommittees/childhoodvaccines/ 

index.html. 

DATES: The meeting will be held on 

December 8, 2017, at 9:00 a.m. ET. 

ADDRESSES: The address for the meeting 

is 5600 Fishers Lane, Rockville, MD, 

Conference Room 5N54. The public can 

join the meeting by: 

1. (In Person) Persons interested in 

attending the meeting in person are 

encouraged to submit a written 

notification to: Annie Herzog, Division 

of Injury Compensation Programs 

(DICP), Healthcare Systems Bureau 

(HSB), HRSA, Room 08N146B, 5600 

Fishers Lane, Rockville, Maryland 

20857 or email: aherzog@hrsa.gov. 

Since this meeting is to be held in a 

federal government building, attendees 

will need to go through a security check 

to enter the building and participate in 

the meeting. Written notification is 

encouraged so that a list of attendees 

can be provided to make entry through 

security quicker. Persons may attend in 

person without providing written 

notification, but their entry into the 

building may be delayed due to security 

checks and the requirement to be 

escorted to the meeting by a federal 

government employee. To request an 

escort to the meeting after entering the 

building, call Amber Johnson at (301) 

443–0129. 

2. (Audio Portion) Calling the 

conference phone number 1–800–369– 

1833 and providing the following 

information: 

Leader Name: Dr. Narayan Nair. 

Password: 6706374. 

3. (Visual Portion) Connecting to the 

ACCV Adobe Connect Pro Meeting 

using the following URL: https://

hrsa.connectsolutions.com/accv/ (copy 

and paste the link into your browser if 

it does not work directly, and enter as 

a guest). Participants should call and 

connect 15 minutes prior to the meeting 

in order for logistics to be set up. If you 

have never attended an Adobe Connect 

meeting, please test your connection 

using the following URL: https://

hrsa.connectsolutions.com/common/ 

help/en/support/meeting_test.htm and 

get a quick overview by following URL: 

http://www.adobe.com/go/connectpro_

overview. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requesting information 

regarding the ACCV should contact 

Annie Herzog, Program Analyst, DICP, 

HRSA in one of three ways: (1) Send a 

request to the following address: Annie 

Herzog, Program Analyst, DICP, HSB, 

HRSA, 5600 Fishers Lane, 08N146B, 

Rockville, Maryland 20857; (2) call 

(301) 443–6593; or (3) send an email to 

aherzog@hrsa.gov. 

The ACCV will meet on Friday, 

December 8, 2017, beginning at 9:00 

a.m. ET in the 5600 Fishers Lane 

Building, Conference Room 5N54, 

Rockville, Maryland 20857; however, 

meeting times and locations could 

change. For the latest information 

regarding meeting start time and 

location, please check the ACCV Web 

site: http://www.hrsa.gov/ 

advisorycommittees/childhoodvaccines/ 

index.html. 

SUPPLEMENTARY INFORMATION: The ACCV 

was established by section 2119 of the 

Public Health Service Act (the Act) (42 

U.S.C. 300aa–19), as enacted by Public 

Law (Pub. L.) 99–660, and as 

subsequently amended, and advises the 

Secretary of HHS (the Secretary) on 

issues related to implementation of the 

National Vaccine Injury Compensation 

Program (VICP). 

Other activities of the ACCV include: 

Recommending changes to the Vaccine 

Injury Table at its own initiative or as 

the result of the filing of a petition; 

advising the Secretary in implementing 

section 2127 of the Act regarding the 

need for childhood vaccination 

products that result in fewer or no 

significant adverse reactions; surveying 

federal, state, and local programs and 

activities related to gathering 

information on injuries associated with 

the administration of childhood 

vaccines, including the adverse reaction 

reporting requirements of section 

2125(b) of the Act; advising the 

Secretary on the methods of obtaining, 

compiling, publishing, and using 

credible data related to the frequency 

and severity of adverse reactions 

associated with childhood vaccines; 

consulting on the development or 

revision of Vaccine Information 

Statements; and recommending to the 

Director of the National Vaccine 

Program research related to vaccine 

injuries which should be conducted to 

carry out the VICP. 

The agenda items for the December 8, 

2017, meeting will include, but are not 

limited to, review of petitions to add 

injuries to the vaccine injury table, and 

updates from DICP, Department of 

Justice (DOJ), National Vaccine Program 

Office (NVPO), Immunization Safety 

Office (Centers for Disease Control and 

Prevention), National Institute of 

Allergy and Infectious Diseases 

(National Institutes of Health), and 

Center for Biologics, Evaluation and 

Research (Food and Drug 

Administration). A draft agenda and 

additional meeting materials will be 

posted on the ACCV Web site (http://

www.hrsa.gov/advisorycommittees/ 

childhoodvaccines/index.html) prior to 

the meeting. Agenda items are subject to 

change as priorities dictate. 

Members of the public will have the 

opportunity to provide comments. Oral 

comments will be honored in the order 

they are requested and may be limited 

as time allows. Requests to make oral 

comments or provide written comments 

to the ACCV should be sent to Annie 

Herzog using the address and phone 

number above by December 4, 2017. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify Annie Herzog, using the address 

and phone number above at least 10 

days prior to the meeting. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2017–24493 Filed 11–9–17; 8:45 am] 

BILLING CODE 4165–15–P 


asabaliauskas on DSKBBXCHB2PROD with NOTICES